{"id":"estradiol-mpa","safety":{"commonSideEffects":[{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Vaginal bleeding or spotting"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Fluid retention"},{"rate":null,"effect":"Increased risk of venous thromboembolism"},{"rate":null,"effect":"Increased risk of stroke"},{"rate":null,"effect":"Increased risk of breast cancer (with long-term use)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Estradiol is a bioidentical estrogen that binds to estrogen receptors to restore circulating estrogen levels, while MPA is a synthetic progestin that provides endometrial protection and additional hormonal effects. Together, this combination addresses vasomotor symptoms, vaginal atrophy, and osteoporosis risk in postmenopausal women.","oneSentence":"Estradiol and medroxyprogesterone acetate (MPA) together provide hormone replacement therapy by supplementing estrogen and progestin to alleviate menopausal symptoms and reduce bone loss.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:32:42.658Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Menopausal vasomotor symptoms (hot flashes, night sweats)"},{"name":"Vulvovaginal atrophy"},{"name":"Osteoporosis prevention in postmenopausal women"}]},"trialDetails":[{"nctId":"NCT06979596","phase":"PHASE2","title":"A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-08-11","conditions":"Malignant Neoplasm","enrollment":250},{"nctId":"NCT07032506","phase":"NA","title":"Intrauterine Stent Placement Following Hysteroscopic Septum Resection","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-03","conditions":"Intrauterine Adhesion","enrollment":320},{"nctId":"NCT03689543","phase":"PHASE2","title":"Estrogen Receptor Beta and Mood","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2019-05-23","conditions":"Perimenopause-Related Depression","enrollment":74},{"nctId":"NCT07020429","phase":"NA","title":"Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-09-01","conditions":"Premature Ovarian Insufficiency","enrollment":276},{"nctId":"NCT03018366","phase":"PHASE2","title":"Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-01-01","conditions":"Estrogen Deficiency, Cardiovascular Disease (CVD), Functional Hypothalamic Amenorrhea","enrollment":29},{"nctId":"NCT06145438","phase":"PHASE3","title":"Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2023-09-04","conditions":"Endometriosis Ovary","enrollment":80},{"nctId":"NCT03751800","phase":"","title":"A Study Run At Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also Be Used to Assess Changes of Severity of HMB in Women with HMB Who Are Treated During 12 Months with a Chronic Hormonal Treatment","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-12-12","conditions":"Menorrhagia","enrollment":422},{"nctId":"NCT05280028","phase":"","title":"HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness","status":"RECRUITING","sponsor":"Far Eastern Memorial Hospital","startDate":"2022-02-07","conditions":"Menopausal Syndrome","enrollment":100},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT06067217","phase":"NA","title":"Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users","status":"UNKNOWN","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2023-09-30","conditions":"Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen","enrollment":52},{"nctId":"NCT00026286","phase":"PHASE3","title":"Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2000-11-28","conditions":"Breast Cancer, Hot Flashes, Menopausal Symptoms","enrollment":""},{"nctId":"NCT03097120","phase":"PHASE3","title":"The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"1995-01","conditions":"Heart Disease","enrollment":309},{"nctId":"NCT04423068","phase":"EARLY_PHASE1","title":"Inpatient Adolescent Contraception","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2020-12-10","conditions":"Pregnancy Related, Contraception, Contraceptive Usage","enrollment":25},{"nctId":"NCT04021017","phase":"PHASE1","title":"PRE-GAiN Bone Health Pilot Study","status":"WITHDRAWN","sponsor":"University of Saskatchewan","startDate":"2020-01-21","conditions":"Anorexia Nervosa","enrollment":""},{"nctId":"NCT01174225","phase":"PHASE4","title":"IUD Insertion Post First Trimester Abortion","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2010-09","conditions":"Contraception","enrollment":534},{"nctId":"NCT01822288","phase":"PHASE4","title":"The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder","status":"COMPLETED","sponsor":"Far Eastern Memorial Hospital","startDate":"2012-11-16","conditions":"Menopausal Syndromes","enrollment":125},{"nctId":"NCT00745108","phase":"PHASE3","title":"Tibolone Endometrium Study (Study 32972)(P06470)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-10-01","conditions":"Postmenopausal Women","enrollment":32},{"nctId":"NCT02122198","phase":"NA","title":"Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-09-08","conditions":"Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction","enrollment":17},{"nctId":"NCT01873170","phase":"","title":"Quantification of Immune Cells in Women Using Contraception (CHIC II)","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-08","conditions":"HIV, Immune Cells (Mucosal and Systemic), Contraception","enrollment":326},{"nctId":"NCT00563576","phase":"NA","title":"Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation","status":"COMPLETED","sponsor":"Columbia University","startDate":"2007-09","conditions":"Metrorrhagia","enrollment":71},{"nctId":"NCT00088153","phase":"PHASE2, PHASE3","title":"Effects of Anorexia Nervosa on Bone Mass in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2003-07","conditions":"Anorexia Nervosa","enrollment":110},{"nctId":"NCT00997893","phase":"PHASE2","title":"Research Investigation of Soy and Estrogen","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2009-12","conditions":"Menopause, Hot Flashes","enrollment":96},{"nctId":"NCT02038335","phase":"","title":"HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2014-02","conditions":"Contraception, HIV, Immune Cells (Mucosal and Systemic)","enrollment":451},{"nctId":"NCT03395756","phase":"EARLY_PHASE1","title":"Depot Medroxyprogesterone Acetate as Emergency Contraception","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2018-08-31","conditions":"Emergency Contraception, Contraception","enrollment":30},{"nctId":"NCT01699022","phase":"PHASE1, PHASE2","title":"Pharmacokinetic and Pharmacodynamic Study of Cyclofem","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2010-06","conditions":"Contraception","enrollment":17},{"nctId":"NCT02617108","phase":"NA","title":"Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis","status":"UNKNOWN","sponsor":"Fu Xing Hospital, Capital Medical University","startDate":"2019-12","conditions":"Uterine Septum","enrollment":310},{"nctId":"NCT02922348","phase":"PHASE3","title":"Hormone Replacement for Premature Ovarian Insufficiency","status":"WITHDRAWN","sponsor":"University of Pennsylvania","startDate":"2016-03-01","conditions":"Primary Ovarian Insufficiency","enrollment":""},{"nctId":"NCT02792153","phase":"PHASE1","title":"Estradiol and Fear Extinction in Anorexia Nervosa (AN)","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2016-12","conditions":"Anorexia Nervosa","enrollment":""},{"nctId":"NCT00066157","phase":"PHASE2, PHASE3","title":"Alzheimer's Disease: Therapeutic Potential of Estrogen","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-09","conditions":"Alzheimer Disease","enrollment":42},{"nctId":"NCT00302731","phase":"PHASE2","title":"Bioidentical 'Natural' Hormone Evaluation in Early Menopause","status":"TERMINATED","sponsor":"Jeanne Drisko, MD, CNS, FACN","startDate":"2006-02","conditions":"Menopause","enrollment":21},{"nctId":"NCT01265017","phase":"PHASE1","title":"Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Sansum Diabetes Research Institute","startDate":"2012-07","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT02272647","phase":"PHASE1","title":"Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-12","conditions":"Healthy","enrollment":47},{"nctId":"NCT03443089","phase":"PHASE1","title":"Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate","status":"COMPLETED","sponsor":"Galeno Desenvolvimento de Pesquisas Clínicas","startDate":"2017-03-31","conditions":"Contraception","enrollment":24},{"nctId":"NCT02855632","phase":"NA","title":"The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis","status":"UNKNOWN","sponsor":"Sir Run Run Shaw Hospital","startDate":"2016-08","conditions":"Intrauterine Adhesion","enrollment":240},{"nctId":"NCT03264781","phase":"PHASE1, PHASE2","title":"The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2016-08","conditions":"Uterine Bleeding","enrollment":44},{"nctId":"NCT00370019","phase":"PHASE2","title":"Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure","status":"WITHDRAWN","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2006-08-25","conditions":"Premature Ovarian Failure","enrollment":""},{"nctId":"NCT02984696","phase":"NA","title":"Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea","status":"UNKNOWN","sponsor":"Catholic University of the Sacred Heart","startDate":"2015-03","conditions":"Hypothalamic Amenorrhea","enrollment":20},{"nctId":"NCT02872818","phase":"PHASE4","title":"Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Kayseri Education and Research Hospital","startDate":"2014-10","conditions":"Apoptotic Signal Pathways in Endometrial Hyperplasia","enrollment":40},{"nctId":"NCT01109979","phase":"PHASE4","title":"Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2009-12","conditions":"Cardiovascular Diseases","enrollment":24},{"nctId":"NCT00000559","phase":"PHASE3","title":"Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1995-03","conditions":"Cardiovascular Diseases, Coronary Disease, Heart Diseases","enrollment":""},{"nctId":"NCT00000466","phase":"PHASE3","title":"Postmenopausal Estrogen/Progestin Interventions (PEPI)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1987-09","conditions":"Bone Diseases, Cardiovascular Diseases, Coronary Disease","enrollment":""},{"nctId":"NCT00083824","phase":"PHASE2, PHASE3","title":"Estrogen, HDL, and Coronary Heart Disease in Women","status":"COMPLETED","sponsor":"Tufts University","startDate":"2004-03","conditions":"Cardiovascular Diseases, Coronary Disease, Heart Diseases","enrollment":309},{"nctId":"NCT00668603","phase":"NA","title":"Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)","status":"COMPLETED","sponsor":"University of Helsinki","startDate":"2005-08","conditions":"Postmenopausal Vasomotor Symptoms, Cardiovascular Disease","enrollment":160},{"nctId":"NCT00044837","phase":"PHASE1","title":"Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":120},{"nctId":"NCT00420342","phase":"PHASE2","title":"Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-01","conditions":"Postmenopause, Hypertension, Pre-Hypertension","enrollment":92},{"nctId":"NCT00350480","phase":"NA","title":"Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2003-04","conditions":"Uterine Hemorrhage, Menorrhagia","enrollment":240},{"nctId":"NCT00463450","phase":"PHASE3","title":"Efficacy of Gynodian® Depot in Women With Impaired Well-being","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-05","conditions":"Hormone Replacement Therapy","enrollment":140},{"nctId":"NCT01056042","phase":"PHASE4","title":"Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2007-06","conditions":"Endometriosis","enrollment":112},{"nctId":"NCT00808132","phase":"PHASE3","title":"Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-01","conditions":"Menopause, Osteoporosis","enrollment":1886},{"nctId":"NCT00242710","phase":"PHASE3","title":"Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women","status":"COMPLETED","sponsor":"Pfizer","startDate":"2005-09","conditions":"Endometrial Hyperplasia, Osteoporosis","enrollment":1083},{"nctId":"NCT00000419","phase":"PHASE3","title":"Safety of Estrogens in Lupus: Hormone Replacement Therapy","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"1996-04","conditions":"Systemic Lupus Erythematosus","enrollment":350},{"nctId":"NCT00033358","phase":"PHASE2","title":"Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2002-02","conditions":"Endometrial Cancer","enrollment":52},{"nctId":"NCT01698164","phase":"PHASE4","title":"Multi-centre Clinical Trial on Hormone Replacement Treatment in China","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2008-12","conditions":"Menopausal Syndrome, Cardiovascular Disease, Osteoporosis","enrollment":1200},{"nctId":"NCT00000897","phase":"NA","title":"A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":42},{"nctId":"NCT01087593","phase":"NA","title":"Estrogens Effect on Pain in Postmenopausal Women Suffering of Fibromyalgia","status":"TERMINATED","sponsor":"Ostergotland County Council, Sweden","startDate":"2001-08","conditions":"Fibromyalgia","enrollment":29},{"nctId":"NCT00191113","phase":"PHASE3","title":"Somatropin Treatment to Final Height in Turner Syndrome","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"1989-02","conditions":"Turner Syndrome","enrollment":154},{"nctId":"NCT00860964","phase":"PHASE4","title":"A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women","status":"COMPLETED","sponsor":"Peking Union Medical College","startDate":"1998-02","conditions":"Osteoporosis","enrollment":221},{"nctId":"NCT00006324","phase":"NA","title":"Hormonal Birth Control and the Risk of Acquiring HIV","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1999-12","conditions":"HIV Infections","enrollment":6360},{"nctId":"NCT00401219","phase":"PHASE1","title":"Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-11","conditions":"Estrogen Replacement Therapy","enrollment":""},{"nctId":"NCT00332553","phase":"PHASE2","title":"Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2002-02","conditions":"Vasomotor Symptoms, Endometrial Safety","enrollment":150},{"nctId":"NCT00392093","phase":"PHASE4","title":"Effect of Hormone Replacement Therapy on Lupus Activity","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"1997-11","conditions":"Systemic Lupus Erythematosus","enrollment":108},{"nctId":"NCT00380887","phase":"","title":"Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-06","conditions":"Postmenopause","enrollment":54},{"nctId":"NCT00319566","phase":"PHASE3","title":"Heart and Estrogen-Progestin Replacement Study (HERS)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"1992-07","conditions":"Coronary Heart Disease","enrollment":2430},{"nctId":"NCT00004650","phase":"PHASE3","title":"Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss","status":"COMPLETED","sponsor":"National Institute of Dental and Craniofacial Research (NIDCR)","startDate":"1993-08","conditions":"Osteoporosis","enrollment":150},{"nctId":"NCT00006133","phase":"NA","title":"Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"National Center for Research Resources (NCRR)","startDate":"2000-06","conditions":"Systemic Lupus Erythematosus","enrollment":970}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Estradiol+medroxyprogesterone acetate"],"phase":"marketed","status":"active","brandName":"Estradiol+MPA","genericName":"Estradiol+MPA","companyName":"Brigham and Women's Hospital","companyId":"brigham-and-women-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Estradiol and medroxyprogesterone acetate (MPA) together provide hormone replacement therapy by supplementing estrogen and progestin to alleviate menopausal symptoms and reduce bone loss. Used for Menopausal vasomotor symptoms (hot flashes, night sweats), Vulvovaginal atrophy, Osteoporosis prevention in postmenopausal women.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}